Peptides seem to be everywhere in skincare. They are presented as a kind of catch-all solution for firming, lifting, wrinkle reduction, and collagen rebuilding. Some of those claims are well supported by science. Some are not. And knowing the difference matters quite a lot, because the word "peptide" on a label tells you almost nothing on its own.
Image 1: Jar of skincare cream (Credit: Dupe)
What are peptides?
Think of your skin a little like a construction site. The main building material is collagen, a dense, fibrous protein that keeps skin firm and resistant to sagging. The workers on that site are cells called fibroblasts, which live in the deeper layer of your skin called the dermis. When you are young, fibroblasts are busy and productive. They make collagen efficiently, and the scaffolding of your skin stays strong. As you age, fibroblast activity slows down, collagen production falls, and certain enzymes that break down old collagen begin to get the upper hand.
Peptides are chains of roughly 2 and 50 amino acids, which are the basic building blocks of all proteins. The ones that matter most for anti-aging fall into four functional categories: signal peptides, which stimulate fibroblast activity (essentially tapping the fibroblast on the shoulder and saying, "We need more collagen here"); carrier peptides, which deliver trace elements needed for enzymatic processes; neurotransmitter inhibitor peptides, which interfere with muscle contraction at the neuromuscular junction; and enzyme inhibitor peptides, which suppress the matrix metalloproteinases responsible for collagen breakdown. Each category operates through a different biochemical pathway, and confusing them leads to both poor product design and misleading marketing.
What does the scientific evidence on peptides say?
The most studied signal peptide in skincare is Palmitoyl Pentapeptide-4, sold under the commercial name Matrixyl. In the lab, it has been shown to stimulate the production of collagen types I and III, as well as hyaluronic acid, by binding to receptors on fibroblast cell surfaces and activating the internal pathways those cells use to build the extracellular matrix. A clinical trial using a cream containing this peptide found that after 12 weeks of twice-daily application, expert graders documented meaningful improvements in fine lines and overall skin appearance in the participants (Pintea et al., 2025).
Another well-characterised signal peptide is Dermaxyl, whose active molecule is Palmitoyl Oligopeptide. What makes Dermaxyl particularly interesting from a biological standpoint is its mechanism: the peptide is chemotactic, meaning it physically attracts fibroblasts and monocytes to sites in the skin where the extracellular matrix has been damaged, essentially summoning the repair workforce rather than simply signalling from a distance. In a controlled 56-day study conducted in 24 female volunteers aged 42 to 66, daily application of a formula containing 2% Dermaxyl produced a statistically significant mean reduction of 13.7% in main wrinkle volume and a 10.1% reduction in wrinkle depth, with individual results in the highest-responding participants reaching reductions of 36% and 27% respectively. It is worth noting that Dermaxyl is also formulated with ceramide 2, the lipid molecule that forms part of the stratum corneum's own mortar layer, which simultaneously supports barrier integrity while the peptide gets to work in the dermis (Sederma).
A third body of evidence comes from a rigorous randomized, double-blind, placebo-controlled clinical trial investigating a serum containing a blend of five neuromodulating and three reparative peptides applied twice daily for 12 weeks by 55 women aged 35 to 60. By the end of the study, 100% of subjects in the peptide group showed measurable improvements in fine lines and overall appearance, 97% showed improved visual skin texture, and there was a statistically significant reduction in wrinkle count and total wrinkle length in the periorbital region measured by three-dimensional clinical photography. No adverse reactions were reported throughout the study (Nguyen et al., 2021).
Image 2: Woman with glowing skin on beach (Credit: Dupe)
Which formulation problems do most products ignore when it comes to peptides?
The clinical evidence described above was generated under controlled conditions using formulations where peptide type, concentration, and delivery vehicle were deliberately designed for efficacy. Most commercial products bearing "peptide complex" on their labels do not operate at that level of rigor.
Fairy dusting, placing peptides at trace concentrations purely to justify a label claim, is a documented formulation practice that is scientifically indefensible. For signal peptides to activate fibroblast receptors, they must reach the dermis at concentrations sufficient to generate a biological response. Peptides placed near the bottom of an ingredient list after the preservative system, with no disclosed concentration or delivery enhancement, are not going to penetrate the stratum corneum in meaningful quantities or encounter fibroblasts in any functionally relevant amount.
Image 3: Woman checking phone skeptically (Credit: Dupe)
What can you look for as a consumer buying skincare with peptides?
From a formulation science standpoint, a peptide product worth taking seriously should name each peptide by its INCI name, disclose or at minimum imply a meaningful concentration, describe the delivery system used to overcome barrier penetration, and reference human clinical data with objective outcome measures. If a product lists a vague "oligopeptide blend" with no further information, the formulation science behind it is almost certainly not worth the premium pricing.
What is the take-home message on peptides?
Peptides are among the most mechanistically interesting actives in modern cosmetic science. The biology is real and the clinical evidence for specific well-designed formulas is solid. What should concern any informed consumer is not the ingredient category but the enormous gap between what the science can achieve and what most products on the market actually deliver.
References
- Pintea A, Manea A, Pintea C, Vlad RA, Birsan M, Antonoaea P, Redai EM, Ciurba A. Peptides: Emerging Candidates for the Prevention and Treatment of Skin Senescence: A Review. Biomolecules. 2025 Jan 9;15(1):88. Available here: https://pmc.ncbi.nlm.nih.gov/articles/PMC11762834/
- Sederma. Dermaxyl Technical Data Sheet and Clinical Study Results. Available here: https://www.scribd.com/document/471490419/DF-Dermaxyl-pdf
- Nguyen TQ, Zahr AS, Kononov T, Ablon G. A Randomized, Double-blind, Placebo-controlled Clinical Study Investigating the Efficacy and Tolerability of a Peptide Serum Targeting Expression Lines. Journal of Clinical and Aesthetic Dermatology. 2021 May;14(5):14-21. Available here: https://pmc.ncbi.nlm.nih.gov/articles/PMC8211334/
This post is for informational purposes only and is not a substitute for professional medical advice.
